Lori J. Wirth, MD, discusses safety data from the phase 3 SELECT trial which evaluated lenvatinib in radioactive ...

During a Case-Based Roundtable® event, Lori A. Leslie, MD, discussed Bruton tyrosine kinase inhibition options for a patient ...

The initial public offer (IPO) of Jamnagar-based Winsol Engineering has been receiving a bumper response from investors with ...

Refractory Shapes IPO opens for subscription on May 6, with a price band of ₹27 to ₹31 per share. Lot size is 4,000 shares.

Refractory Shapes IPO GMP: Shares of Refractory Shapes traded ₹ 5 higher in the grey market against its issue price. This ...

Refractory Shapes IPO aims to raise Rs 18.6 crore, listing on NSE SME platform. Subscription from tomorrow to May 9. Offers ...

XyloCor Therapeutics, Inc. recently revealed the final results from the Phase 2 segment of its EXACT clinical trial at the ...

SCY-247’s IND-enabling activities continue to progress, with initiation of Phase I anticipated in the second half of 2024Clinical study reports ...

The units of the Defence Forces of Ukraine have blocked the assault groups of the Russian occupying army that broke through ...

New therapies are helping patients, but are also driving up overall costs of care. Commercially insured patients with ...

GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based ...

Ukrainian soldiers stopped Russian assault groups on the territory of the Krasnohorivka refractory plant, according to ...